ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

IDALMIS SANTANA-PORBEN MD

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 228 out of 3593

$1.04M Total Retail Price of All Prescriptions

Rank: 120 out of 3593

599 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 13,457 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 779 656 1 2
CRESTOR 765 659 2 21
LOSARTAN POTASSIUM 720 652 3 14
CITALOPRAM HBR 623 572 4 25
METOPROLOL SUCCINATE 623 548 4 19
ATORVASTATIN CALCIUM 614 526 6 15
SIMVASTATIN 490 422 7 1
OMEPRAZOLE 477 422 8 5
CARVEDILOL 458 384 9 23
METFORMIN HCL 424 283 10 6
AMLODIPINE BESYLATE 381 316 11 3
VIAGRA 347 274 12 84
LEVOTHYROXINE SODIUM 342 307 13 4
LOSARTAN-HYDROCHLOROTHIAZIDE 283 245 14 48
GABAPENTIN 272 225 15 16
SYMBICORT 258 230 16 160
ZOSTAVAX 245 208 17 168
RANITIDINE HCL 199 165 18 27
ALENDRONATE SODIUM 186 182 19 22
ATENOLOL 180 153 20 11
FUROSEMIDE 179 145 21 9
HYDROCODONE-ACETAMINOPHEN 176 124 S3 22 7
WARFARIN SODIUM 175 156 23 18
TRAMADOL HCL 171 132 24 17
SPIRIVA 165 151 25 87
HYDROCHLOROTHIAZIDE 153 131 26 10
IBUPROFEN 149 114 27 43
ADVAIR DISKUS 144 137 28 47
NEXIUM 143 111 29 36
PROAIR HFA 142 129 30 54
PRAVASTATIN SODIUM 138 121 31 13
INSULIN SYRINGE 133 116 32 91
GLIPIZIDE 128 86 33 40
LOVAZA 127 99 34 106
CLOPIDOGREL 123 107 35 30
PEN NEEDLE 122 82 36 188
POTASSIUM CHLORIDE 118 103 37 24
FENOFIBRATE 118 103 37 39
GLIPIZIDE ER 116 95 39 101
TAMSULOSIN HCL 114 112 40 33
ISOSORBIDE MONONITRATE ER 113 92 41 61
LEVEMIR FLEXPEN 109 75 42 228
SYNTHROID 102 98 43 51
PANTOPRAZOLE SODIUM 101 89 44 45
NOVOLOG FLEXPEN 94 61 45 234
VENTOLIN HFA 93 67 46 80
PLAVIX 92 74 47 42
LORAZEPAM 91 84 48 98
CLOTRIMAZOLE 91 69 48 319
ALPRAZOLAM 78 78 50 37
ALLOPURINOL 75 69 51 35
HYDRALAZINE HCL 70 52 52 107
JANUVIA 66 51 53 81
BYSTOLIC 65 65 54 182
FLUTICASONE PROPIONATE 64 53 55 32
VERAPAMIL ER 62 48 56 99
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 49 57 26
FINASTERIDE 59 59 58 79
NIFEDIPINE ER 58 50 59 75
PREDNISONE 57 53 60 49
DOXYCYCLINE HYCLATE 55 52 61 141
LOVASTATIN 50 50 62 20
TEMAZEPAM 50 50 62 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.